Reaching âherd immunityâ is unlikely in the US, experts believe
Apoorva Mandavilli
Save
Share
New York | Early in the pandemic, when vaccines for the coronavirus were still just a glimmer on the horizon, the term âherd immunityâ came to signify the endgame: the point when enough Americans would be protected from the virus so they could be rid of the pathogen and reclaim their lives.
Now, more than half of adults in the United States have been inoculated with at least one dose of a vaccine. But daily vaccination rates are slipping, and there is consensus among scientists and public health experts that the herd immunity threshold is not attainable â at least not in the foreseeable future, and perhaps not ever.
COVID-19 herd immunity might not happen in the US, say experts CNET 5/3/2021
When will the US reach herd immunity for COVID-19? Actually, we might not.
In an article published by The New York Times, experts argue that many factors are chewing away at the dream of achieving herd immunity, including persistent vaccine hesitancy, individual city or community immunity and the spread of COVID-19 variants. As daily COVID-19 vaccination rates slow and variants continue to spread, some scientists and public health experts are shifting focus away from herd immunity and onto continued vaccination efforts to overcome the pandemic.
Herd immunity, or community immunity, occurs when a large portion of a community (the herd) becomes immune to a disease, making the spread of disease from person to person unlikely, according to the Mayo Clinic. People have immunity after being exposed to a virus, either through vaccination or from infection. Both methods train a person s immune system to
E-Mail
WASHINGTON - The Society for Cardiovascular Angiography and Interventions (SCAI) presented its Master Interventionalists of SCAI (MSCAI) designations during the SCAI 2020 Scientific Sessions Virtual Conference MSCAI recognition ceremony.
The MSCAI designation is awarded to individuals who have demonstrated excellence in invasive/interventional cardiology over the course of their career and for their commitment to the highest levels of clinical care, innovation, publication, and teaching.
This year s MSCAI designations were awarded to the following group of outstanding interventionalists:
Ian C. Gilchrist, MD, MSCAI
Dr. Ian C. Gilchrist is a professor of medicine for Penn State University s College of Medicine at the Hershey Medical Center in Hershey, PA. Dr. Gilchrist graduated from Dartmouth College in Hanover, NH and then obtained his medical degree from Columbia University. He received his residency and cardiology fellowship training at the St. Luke s/Roosevelt Hosp
Apoorva Mandavilli, The New York Times Published: 03 May 2021 02:43 PM BdST Updated: 03 May 2021 02:43 PM BdST People on the National Mall in Washington, April 3, 2021. The New York Times
Early in the pandemic, when vaccines for the coronavirus were still just a glimmer on the horizon, the term “herd immunity” came to signify the endgame: the point when enough Americans would be protected from the virus so we could be rid of the pathogen and reclaim our lives. ); }
Now, more than half of adults in the United States have been inoculated with at least one dose of a vaccine. But daily vaccination rates are slipping, and there is widespread consensus among scientists and public health experts that the herd immunity threshold is not attainable at least not in the foreseeable future, and perhaps not ever.